Rare Disease Drug Gets Tailored FDA Guidance Before Pivotal TrialsBusiness PenMay 5, 2026May 5, 2026 May 5, 2026May 5, 2026 An early-stage gene-therapy program targeting a rare form of childhood blindness has quietly entered a new lane inside the U.S. drug-approval system, one that could...
